share_log

Illumina | 10-Q: Q2 2024 Earnings Report

Illumina | 10-Q: Q2 2024 Earnings Report

Illumina | 10-Q：2024財年二季報
美股SEC公告 ·  2024/08/08 05:32

Moomoo AI 已提取核心訊息

Illumina reported Q2 2024 revenue of $1.11 billion, down 5% year-over-year, with Core Illumina revenue declining 6% to $1.09 billion. The company recorded significant goodwill and intangible impairment charges of $1.89 billion related to GRAIL, leading to a net loss of $1.99 billion. Gross margin improved to 64.8% from 62.2% in Q2 2023, driven by favorable sequencing consumables mix and operational efficiencies.On June 24, 2024, Illumina completed the spin-off of GRAIL, distributing 85.5% of GRAIL shares to stockholders while retaining a 14.5% stake. The company recorded a $328 million unrealized loss on its retained GRAIL investment. To fund the spin-off, Illumina borrowed $750 million through a new delayed draw credit facility at 6.7% interest rate due June 2025.The company ended Q2 with $994 million in cash and investments, including $444 million held overseas. Operating cash flow was $157 million for the first half of 2024. Illumina faces ongoing regulatory challenges, including a €432 million fine from the European Commission related to the GRAIL acquisition, which is being appealed.
Illumina reported Q2 2024 revenue of $1.11 billion, down 5% year-over-year, with Core Illumina revenue declining 6% to $1.09 billion. The company recorded significant goodwill and intangible impairment charges of $1.89 billion related to GRAIL, leading to a net loss of $1.99 billion. Gross margin improved to 64.8% from 62.2% in Q2 2023, driven by favorable sequencing consumables mix and operational efficiencies.On June 24, 2024, Illumina completed the spin-off of GRAIL, distributing 85.5% of GRAIL shares to stockholders while retaining a 14.5% stake. The company recorded a $328 million unrealized loss on its retained GRAIL investment. To fund the spin-off, Illumina borrowed $750 million through a new delayed draw credit facility at 6.7% interest rate due June 2025.The company ended Q2 with $994 million in cash and investments, including $444 million held overseas. Operating cash flow was $157 million for the first half of 2024. Illumina faces ongoing regulatory challenges, including a €432 million fine from the European Commission related to the GRAIL acquisition, which is being appealed.
Illumina報告2024年第二季度營業收入爲11.1億美金，同比下降5%，核心Illumina營業收入下降6%至10.9億美金。公司因涉及GRAIL而計入了18.9億美金的重大商譽和無形資產減值損失，導致淨虧損達19.9億美金。毛利率從2023年第二季度的62.2%提高至64.8%，得益於有利的測序耗材組合和運營效率。2024年6月24日，Illumina完成了GRAIL的分拆，將85.5%的GRAIL股份分配給股東，同時保留14.5%的股份。公司確認了32800萬美金的未實現損失，涉及其持有的GRAIL投資。爲了資助此次分拆，Illumina通過一個新的延期提款信用額度借款75000萬美...展開全部
Illumina報告2024年第二季度營業收入爲11.1億美金，同比下降5%，核心Illumina營業收入下降6%至10.9億美金。公司因涉及GRAIL而計入了18.9億美金的重大商譽和無形資產減值損失，導致淨虧損達19.9億美金。毛利率從2023年第二季度的62.2%提高至64.8%，得益於有利的測序耗材組合和運營效率。2024年6月24日，Illumina完成了GRAIL的分拆，將85.5%的GRAIL股份分配給股東，同時保留14.5%的股份。公司確認了32800萬美金的未實現損失，涉及其持有的GRAIL投資。爲了資助此次分拆，Illumina通過一個新的延期提款信用額度借款75000萬美金，利率爲6.7%，到期日爲2025年6月。公司在第二季度結束時擁有現金和投資99400萬美金，其中包括境外持有的44400萬美金。2024年上半年的經營現金流爲15700萬美金。Illumina面臨持續的監管挑戰，包括與GRAIL收購相關的43200萬歐元罰款，正在上訴中。

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

獨立文件8  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Prenetics Global
    PRE
    -- 4.0000
    NeoGenomics
    NEO
    -- 9.620
    Fulgent Genetics
    FLGT
    -- 17.050
    恩佐生化
    ENZ
    -- 0.431
    Personalis
    PSNL
    -- 3.620
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    FOMC維持利率但不確定性高企：美股後市走向如何？
    🎙️討論 1. 美聯儲強調政策路徑存在「高度不確定性」，你更關注利率預期變化還是經濟數據對市場的短期影響？ 2. 若核心通脹維持高位，哪類板塊更具交易機會——防禦型股票還是科技成長股？ 展开
    聯邦公開市場委員會新聞發佈會，2025年3月19日